A Study of Chinese Adults With Lymphoma

CompletedOBSERVATIONAL
Enrollment

934

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Lymphoma
Trial Locations (19)

100000

Beijing Cancer Hospital, Beijing

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Peking Union Medical College Hospital, Beijing

201321

Fudan University Shanghai Cancer Center, Shanghai

Zhongshan Hospital, Fudan University, Shanghai

210000

Jiangsu Province Hospital, Nanjing

215000

The First Affiliated Hospital of Soochow University, Suzhou

250000

Qilu Hospital of Shandong University, Jinan

266000

Affiliated Hospital of Qingdao University, Qingdao

300000

Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin

Tianjin Medical University Cancer Hospital, Tianjin

350000

Fujian Cancer Hospital, Fuzhou

Fujian Medical University Union Hospital, Fuzhou

430000

Tongji Medical College of Hust, Wuhan

450000

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510000

Sun Yat-sen University Cancer Center, Guangzhou

610000

West China Hospital of Sichuan University, Chengdu

030000

Shanxi Cancer Hospital, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY